September 23-25, 2026
Hynes Convention CenterBoston, MAKey Sessions
Anthony Davies
Keynote Panel Discussion: Big Pharma’s CGT Playbook - Top Investment Priorities and Emerging Opportunities
Dark Horse Consulting Group Inc.
keyboard_arrow_right
Search & Filter keyboard_arrow_right
keyboard_arrow_left Hide
Tuesday 16th September, 2025 - Workshop & Keynotes - ET (Eastern Time, GMT-05:00)
keyboard_arrow_leftSearch & Filter
search
Streams
Clear
Tuesday 16th September, 2025 - Workshop & Keynotes - ET (Eastern Time, GMT-05:00)
search
Streams
Clear
Showing 1 of 1 Streams
Keynote Plenary
2:00pm - 2:05pm
Welcome to Cell and Gene Therapy International and Chairperson’s Opening Remarks
- Catherine Simpson - Conference Director - Cell and Gene Therapy Portfolio, Informa Connect LifeSciences
2:05pm - 2:50pm
Keynote Panel Discussion: Big Pharma’s CGT Playbook - Top Investment Priorities and Emerging Opportunities
- Anthony Davies - Founder & CEO, Dark Horse Consulting Group Inc.
- Wolfram Carius - EVP Pharmaceuticals, Bayer
- Erin Kimbrel - Head of Cell and Gene Research, Astellas Pharma Inc.
- Stephen Kennedy - Head of Technical Operations, CRISPR Therapeutics
- Ruth Salmon - VP, BMS Cell Therapy Research, Bristol Myers Squibb
2:50pm - 3:30pm
Investor Panel Discussion: Investments in Cell and Gene Therapies and Enabling Technologies
- Bryan Poltilove - Strategic Advisor and Independent Board Director, Independent
- Daniel Friedman - Principal, BroadOak Capital
- Jose Navarro-Betancourt, MD, PhD - Scientific Director, quadraScope Ventures
- Mary Schaheen - President and Director, Prevail Partners
Filter
Streams
Clear